t2cure Company
t2cure is a biopharmaceutical company develops novel progenitor cell based regenerative therapeutics to provide new treatment.
Technology:
Cell therapy
Industry:
Cell Therapy, Private
Headquarters:
Frankfurt, Hessen, Germany
Founded Date:
2006-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
2
Estimated Revenue:
$1M to $10M
Last Funding Date:
2006-07-01
Last Funding Type:
Series A
Register and Claim Ownership